These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


PUBMED FOR HANDHELDS

Journal Abstract Search


207 related items for PubMed ID: 32638368

  • 21.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 22. Evaluation of the Reliability and Validity of the Persian Version of Urticaria Control Test (UCT).
    Khoshkhui M, Weller K, Fadaee J, Maurer M, Jabbari Azad F, Emadzadeh M.
    Iran J Allergy Asthma Immunol; 2021 Aug 07; 20(4):423-431. PubMed ID: 34418896
    [Abstract] [Full Text] [Related]

  • 23. Probiotic as an adjuvant therapy in chronic urticaria: a blinded randomized controlled clinical trial.
    Atefi N, Fallahpour M, Sharifi S, Ghassemi M, Roohaninasab M, Goodarzi A.
    Eur Ann Allergy Clin Immunol; 2022 May 07; 54(3):123-130. PubMed ID: 33939347
    [Abstract] [Full Text] [Related]

  • 24. A Specialized Therapeutic Approach to Chronic Urticaria Refractory to H1-Antihistamines Improves Disease Burden: The Spanish AWARE Experience.
    Gimenez-Arnau A, Bartra J, Ferrer M, Jauregui I, Borbujo J, Figueras I, Muñoz-Bellido FJ, Pedraz J, Serra-Baldrich E, Tejedor-Alonso MA, Velasco M, Terradas P, Labrador M.
    J Investig Allergol Clin Immunol; 2022 Jun 20; 32(3):191-199. PubMed ID: 33349612
    [Abstract] [Full Text] [Related]

  • 25. Association of Chronic Urticaria with Psychological Distress: A Multicentre Cross-sectional Study.
    Tawil S, Irani C, Kfoury R, Abramian S, Salameh P, Weller K, Maurer M, Ezzedine K.
    Acta Derm Venereol; 2023 Feb 14; 103():adv00865. PubMed ID: 36129251
    [Abstract] [Full Text] [Related]

  • 26. The evaluation of melatonin levels in chronic spontaneous urticaria: A case control study.
    Can A, Tuzer OC.
    Allergy Asthma Proc; 2023 Nov 15; 44(6):e29-e35. PubMed ID: 37714684
    [Abstract] [Full Text] [Related]

  • 27. Validity and reliability of the Indonesian version of the Chronic Urticaria Quality of Life Questionnaire (CU-Q2oL).
    Nuary T, Budianti WK, Indriatmi W, Baiardini I.
    Asian Pac J Allergy Immunol; 2021 Jul 11. PubMed ID: 34246221
    [Abstract] [Full Text] [Related]

  • 28. The burden of chronic spontaneous urticaria: unsatisfactory treatment and healthcare resource utilization in France (the ASSURE-CSU study).
    Lacour JP, Khemis A, Giordano-Labadie F, Martin L, Staumont-Salle D, Hacard F, Tian H, McBride D, Hollis K, Hunter S, Martin L, Lamirand A, Le Guen S, Balp MM, Berard F.
    Eur J Dermatol; 2018 Dec 01; 28(6):795-802. PubMed ID: 30698148
    [Abstract] [Full Text] [Related]

  • 29. Does replacement of vitamin D reduce the symptom scores and improve quality of life in patients with chronic urticaria?
    Oguz Topal I, Kocaturk E, Gungor S, Durmuscan M, Sucu V, Yıldırmak S.
    J Dermatolog Treat; 2016 Dec 01; 27(2):163-6. PubMed ID: 26295454
    [Abstract] [Full Text] [Related]

  • 30. Rupatadine in Established Treatment Schemes Improves Chronic Spontaneous Urticaria Symptoms and Patients' Quality of Life: a Prospective, Non-interventional Trial.
    Metz M, Weller K, Neumeister C, Izquierdo I, Bödeker RH, Schwantes U, Maurer M.
    Dermatol Ther (Heidelb); 2015 Dec 01; 5(4):217-230. PubMed ID: 26591001
    [Abstract] [Full Text] [Related]

  • 31. Epidemiological and clinical characteristics of adult patients with chronic spontaneous urticaria in Latvia: insights from a two-centre study.
    Sokolovskis A, Lapiņa L, Lauva A, Papirte S, Zolovs M, Ciekure L, Mauliņš E, Lielmane L, Kriķe P, Selicka M, Puriņa S, Kurjāne N.
    Eur J Dermatol; 2024 Aug 01; 34(4):398-408. PubMed ID: 39193677
    [Abstract] [Full Text] [Related]

  • 32. Spiritual well-being and quality of life are impaired in chronic urticaria.
    Dortas Junior SD, Azizi GG, Moret RN, Bastos Junior RM, Valle SOR.
    Eur Ann Allergy Clin Immunol; 2021 Sep 01; 53(5):221-227. PubMed ID: 33728832
    [Abstract] [Full Text] [Related]

  • 33. Omalizumab in patients with chronic spontaneous urticaria nonresponsive to H1-antihistamine treatment: results of the phase IV open-label SUNRISE study.
    Bérard F, Ferrier Le Bouedec MC, Bouillet L, Reguiai Z, Barbaud A, Cambazard F, Milpied B, Pelvet B, Kasujee I, Gharbi H, Lacour JP.
    Br J Dermatol; 2019 Jan 01; 180(1):56-66. PubMed ID: 29927483
    [Abstract] [Full Text] [Related]

  • 34. Effectiveness, safety, and tolerability of bilastine 20 mg vs levocetirizine 5 mg for the treatment of chronic spontaneous urticaria: A double-blind, parallel group, randomized controlled trial.
    Podder I, Das A, Ghosh S, Biswas D, Sengupta S, Chowdhury SN.
    Dermatol Ther; 2020 Nov 01; 33(6):e13946. PubMed ID: 32618048
    [Abstract] [Full Text] [Related]

  • 35. Chronic urticaria treatment patterns and changes in quality of life: AWARE study 2-year results.
    Maurer M, Giménez-Arnau A, Ensina LF, Chu CY, Jaumont X, Tassinari P.
    World Allergy Organ J; 2020 Sep 01; 13(9):100460. PubMed ID: 32983330
    [Abstract] [Full Text] [Related]

  • 36. Urticaria from the Neurodermatological Perspective: A Temporal Analysis of Urticaria and Cognition.
    A T, Lambrou GI, Kyritsi A, Geronikolou SA, Nikolaidou E, Katsarou A, Chatziioannou A, Stratigos A, Rigopoulos D.
    Adv Exp Med Biol; 2021 Sep 01; 1339():209-220. PubMed ID: 35023108
    [Abstract] [Full Text] [Related]

  • 37. The Efficacy and Safety of High Dose (10 mg) of Desloratadine (Dazit® 10) in the Treatment of Chronic Spontaneous Urticaria in India: A Phase III, Multicentric, Open-Label, Single-Arm Study.
    Kapadia S, Nageswaramma S, Shah K, Singh A, Mahajan SC, Deshpande A, Chakraborty S, Kar BR, Padmaja P, Bharija SC, Doshi M, Ghadge P, Gabhane M, Dharmadhikari S, Mane A, Mehta S.
    Cureus; 2024 Jan 01; 16(1):e53125. PubMed ID: 38420062
    [Abstract] [Full Text] [Related]

  • 38. Headache deteriorates the quality of life in children with chronic spontaneous urticaria.
    Filiz S, Kutluk MG, Uygun DFK.
    Allergol Immunopathol (Madr); 2019 Jan 01; 47(3):254-259. PubMed ID: 30686612
    [Abstract] [Full Text] [Related]

  • 39. Chronic urticaria in most patients is poorly controlled. Results of the development, validation, and real life application of the arabic urticaria control test.
    Irani C, Hallit S, Weller K, Maurer M, El Haber C, Salameh P.
    Saudi Med J; 2017 Dec 01; 38(12):1230-1236. PubMed ID: 29209673
    [Abstract] [Full Text] [Related]

  • 40. The Alarmin Triad-IL-25, IL-33, and TSLP-Serum Levels and Their Clinical Implications in Chronic Spontaneous Urticaria.
    Dobrican-Băruța CT, Deleanu DM, Muntean IA, Nedelea I, Bălan RG, Filip GA, Procopciuc LM.
    Int J Mol Sci; 2024 Feb 07; 25(4):. PubMed ID: 38396704
    [Abstract] [Full Text] [Related]


    Page: [Previous] [Next] [New Search]
    of 11.